Status and phase
Conditions
Treatments
About
The RENEWAL 3 AVT device is designed to treat patients suffering from HF, with a history of or at risk of developing atrial and ventricular arrhythmias
Full description
A clinical evaluation to:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients who meet the following criteria should be given consideration for inclusion in the clinical investigation:
NOTE: Guidant recommends anticoagulation therapy per physician discretion.
Exclusion criteria
Patients who will be excluded from the investigation are those who meet any one of the following criteria:
Note: Women of childbearing potential must have a negative pregnancy test within 7 days of enrollment
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal